ASCO is practically a year away.
A lot can happen between now and then.
I really think it would be premature to say its all "up" from here.
Judging from recent talks I have had, I do not think Ariad is going to have any partner going into the Fall pivotal '534 trial. They are, however, needing one for other indications such a First-line (it sounds like they want to pursue this)....which is fine with me....as long as someone else is funding that study.